264.84
price up icon0.52%   +1.38
pre-market  Pre-market:  262.99   -1.85   -0.70%
loading
Danaher Corp. stock is currently priced at $264.84, with a 24-hour trading volume of 3.38M. It has seen a +0.52% increased in the last 24 hours and a +10.19% rose in the past month. The chart indicates a potential bullish trend, as the stock is above the $262.4 pivot point. If it approaches the $265.1 resistance level, significant changes may occur.
Previous Close:
$263.46
Open:
$262.46
24h Volume:
3.38M
Market Cap:
$196.16B
Revenue:
$22.52B
Net Income/Loss:
$4.40B
P/E Ratio:
33.40
EPS:
7.93
Net Cash Flow:
$5.55B
1W Performance:
+5.33%
1M Performance:
+10.19%
6M Performance:
+26.65%
1Y Performance:
+17.71%
1D Range:
Value
$261.55
$265.37
52W Range:
Value
$182.09
$269.61

Danaher Corp. Stock (DHR) Company Profile

Name
Name
Danaher Corp.
Name
Phone
202-828-0850
Name
Address
2200 Pennsylvania Avenue NW, Suite 800W, Washington, DC
Name
Employee
67,000
Name
Twitter
@Danaher_U
Name
Next Earnings Date
2024-05-14
Name
Latest SEC Filings
Name
DHR's Discussions on Twitter

Danaher Corp. Stock (DHR) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-24-24 Downgrade Barclays Overweight → Equal Weight
Dec-18-23 Initiated HSBC Securities Hold
Dec-13-23 Resumed Wolfe Research Peer Perform
Dec-07-23 Downgrade Goldman Buy → Neutral
Jul-19-23 Initiated Raymond James Outperform
May-01-23 Initiated SVB Securities Outperform
Apr-26-23 Downgrade BofA Securities Buy → Neutral
Apr-18-23 Upgrade Wells Fargo Equal Weight → Overweight
Jan-05-23 Downgrade Credit Suisse Outperform → Neutral
Dec-14-22 Initiated Deutsche Bank Buy
Oct-24-22 Downgrade The Benchmark Company Buy → Hold
Aug-25-22 Initiated Credit Suisse Outperform
Aug-17-22 Resumed Bernstein Outperform
Jul-20-22 Initiated UBS Buy
Jun-01-22 Upgrade RBC Capital Mkts Sector Perform → Outperform
Apr-25-22 Downgrade Wells Fargo Overweight → Equal Weight
Jan-11-22 Initiated Bernstein Outperform
Oct-15-21 Resumed Cowen Outperform
Sep-10-21 Reiterated BofA Securities Buy
Aug-05-21 Resumed Credit Suisse Outperform
Jul-23-21 Reiterated Goldman Buy
Jul-16-21 Initiated The Benchmark Company Buy
Apr-07-21 Resumed Robert W. Baird Outperform
Mar-03-21 Resumed Barclays Overweight
Dec-02-20 Initiated Goldman Buy
Nov-25-20 Downgrade RBC Capital Mkts Outperform → Sector Perform
Nov-10-20 Initiated KeyBanc Capital Markets Overweight
Jun-16-20 Upgrade Wolfe Research Peer Perform → Outperform
Apr-02-20 Downgrade Wolfe Research Outperform → Peer Perform
Mar-26-20 Upgrade RBC Capital Mkts Sector Perform → Outperform
Feb-03-20 Reiterated Needham Buy
Jan-08-20 Initiated Wells Fargo Overweight
Jan-07-20 Initiated Citigroup Buy
Nov-15-19 Resumed Stifel Hold
Oct-28-19 Reiterated Needham Buy
Oct-14-19 Resumed Credit Suisse Outperform
Jul-19-19 Reiterated Needham Buy
Jun-11-19 Initiated Piper Jaffray Neutral
May-30-19 Initiated Wolfe Research Outperform
Apr-17-19 Reiterated Needham Buy
Feb-28-19 Reiterated Needham Buy
Feb-25-19 Upgrade Janney Neutral → Buy
Jan-03-19 Initiated Needham Buy
Apr-20-18 Reiterated Stifel Buy
View All

Danaher Corp. Stock (DHR) Financials Data

Danaher Corp. (DHR) Revenue 2024

DHR reported a revenue (TTM) of $22.52 billion for the quarter ending March 31, 2024, a -9.58% decline year-over-year.
loading

Danaher Corp. (DHR) Net Income 2024

DHR net income (TTM) was $4.40 billion for the quarter ending March 31, 2024, a -36.52% decrease year-over-year.
loading

Danaher Corp. (DHR) Cash Flow 2024

DHR recorded a free cash flow (TTM) of $5.55 billion for the quarter ending March 31, 2024, a -24.66% decrease year-over-year.
loading

Danaher Corp. (DHR) Earnings per Share 2024

DHR earnings per share (TTM) was $5.90 for the quarter ending March 31, 2024, a -36.42% decline year-over-year.
loading

Danaher Corp. Stock (DHR) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Blair Rainer
President & CEO
May 14 '24
Option Exercise
59.91
19,085
1,143,435
135,080
Blair Rainer
President & CEO
May 14 '24
Sale
255.00
19,085
4,866,675
115,995
McGrew Matthew
EVP & Chief Financial Officer
May 10 '24
Option Exercise
61.25
25,174
1,541,794
45,338
McGrew Matthew
EVP & Chief Financial Officer
May 10 '24
Sale
253.05
46,377
11,735,856
29,407
SPOON ALAN G
Director
May 02 '24
Option Exercise
52.56
3,289
172,870
116,910
SPOON ALAN G
Director
May 02 '24
Sale
243.58
708
172,455
116,202
Weidemanis Joakim
Executive Vice President
Apr 25 '24
Option Exercise
58.48
22,433
1,311,882
112,845
Weidemanis Joakim
Executive Vice President
Apr 25 '24
Sale
250.46
22,433
5,618,569
90,412
Blair Rainer
President & CEO
Apr 24 '24
Option Exercise
59.91
38,170
2,286,870
154,165
Blair Rainer
President & CEO
Apr 24 '24
Sale
249.22
47,175
11,756,725
115,995
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors. Its Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and flow cytometry products. The company offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. Its Dental segment provides consumables, equipment, and services to diagnose, treat, and prevent disease and ailments of the teeth, gums, and supporting bone. This segment offers implant systems, dental prosthetics, and associated treatment planning software; orthodontic bracket systems and lab products; endodontic systems and related consumables; restorative materials and instruments; infection prevention products; digital imaging systems and software; air and electric powered handpieces, and consumables; and treatment units. Its Environmental & Applied Solutions segment offers instrumentation, services, and disinfection systems to analyze, treat, and manage water in residential, commercial, industrial, and natural resource applications. This segment also provides equipment, software, services, and consumables for packaging, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
diagnostics_research TMO
$597.15
price down icon 0.31%
diagnostics_research A
$154.31
price up icon 0.15%
$540.94
price down icon 1.38%
diagnostics_research IQV
$235.00
price up icon 0.56%
diagnostics_research MTD
$1,530.55
price up icon 0.70%
Cap:     |  Volume (24h):